- Home
- HVT vs GALT Comparison
HVT vs GALT Comparison
Compare HVT & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HVT | GALT |
|---|---|---|
| Founded | 1885 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 435.8M | 397.3M |
| IPO Year | 1994 | 2008 |
Fundamental Metrics
Financial Performance| Metric | HVT | GALT |
|---|---|---|
| Price | $26.16 | $3.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | 102.0K | ★ 191.8K |
| Earning Date | 11-04-2026 | 11-24-2026 |
| Dividend Yield | ★ 5.04% | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $758,995,000.00 | N/A |
| Revenue This Year | $6.24 | N/A |
| Revenue Next Year | $7.91 | N/A |
| P/E Ratio | $34.08 | ★ N/A |
| Revenue Growth | ★ 4.99 | N/A |
| 52 Week Low | $20.10 | $2.03 |
| 52 Week High | $30.60 | $7.13 |
Technical Indicators
Market Signals| Indicator | HVT | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 37.57 | 47.32 |
| Support Level | $24.22 | $2.71 |
| Resistance Level | $26.87 | $4.10 |
| Average True Range (ATR) | 1.32 | 0.27 |
| MACD | -0.44 | 0.01 |
| Stochastic Oscillator | 14.49 | 59.37 |
Price Performance
Historical ComparisonAbout HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.